These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 7903383
1. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells. Shin Y, Romstedt KJ, Miller DD, Feller DR. J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383 [Abstract] [Full Text] [Related]
2. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta. Romstedt KJ, Shin Y, Shams G, Doyle K, Tantishaiyakul V, Clark MT, Adejare A, Hamada A, Miller DD, Feller DR. Biochem Pharmacol; 1993 Dec 03; 46(11):2051-9. PubMed ID: 8267653 [Abstract] [Full Text] [Related]
3. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues. Shams G, Romstedt KJ, Gerhardt MA, Harrold MW, Miller DD, Feller DR. Eur J Pharmacol; 1990 Aug 02; 184(1):21-31. PubMed ID: 1976530 [Abstract] [Full Text] [Related]
4. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta. Mukhopadhyay A, Navran SS, Amin HM, Abdel-Aziz SA, Chang J, Sober DJ, Miller DD, Feller DR. J Pharmacol Exp Ther; 1985 Jan 02; 232(1):1-9. PubMed ID: 3855323 [Abstract] [Full Text] [Related]
5. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo. Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR. Chirality; 1991 Jan 02; 3(2):112-7. PubMed ID: 1830752 [Abstract] [Full Text] [Related]
6. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands. De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD. J Med Chem; 1996 Sep 13; 39(19):3701-11. PubMed ID: 8809159 [Abstract] [Full Text] [Related]
7. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites. Ahn CH, Wallace LJ, Miller DD, Feller DR. Thromb Res; 1988 May 01; 50(3):387-99. PubMed ID: 2969151 [Abstract] [Full Text] [Related]
8. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade. Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR. Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894 [Abstract] [Full Text] [Related]
9. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists. Shams G, Wallace LJ, Miller DD, Feller DR. Pharmacology; 1990 Aug 01; 40(1):27-32. PubMed ID: 2139513 [Abstract] [Full Text] [Related]
10. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities. Markovich KM, Tantishaiyakul V, Hamada A, Miller DD, Romstedt KJ, Shams G, Shin Y, Fraundorfer PF, Doyle K, Feller DR. J Med Chem; 1992 Feb 07; 35(3):466-79. PubMed ID: 1346651 [Abstract] [Full Text] [Related]
11. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues. Fedyna JS, Adejare A, Miller DD, Feller DR. Eur J Pharmacol; 1987 Mar 17; 135(2):161-71. PubMed ID: 2884118 [Abstract] [Full Text] [Related]
12. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies. Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD, Feller DR. Chirality; 1994 Mar 17; 6(2):76-85. PubMed ID: 7911313 [Abstract] [Full Text] [Related]
13. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity. Christoff JJ, Bradley L, Miller DD, Lei L, Rodriguez F, Fraundorfer P, Romstedt K, Shams G, Feller DR. J Med Chem; 1997 Jan 03; 40(1):85-91. PubMed ID: 9016331 [Abstract] [Full Text] [Related]
14. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. Shams G, Romstedt KJ, Lust LA, Clark MT, Miller DD, Feller DR. Gen Pharmacol; 1997 Feb 03; 28(2):323-30. PubMed ID: 9013212 [Abstract] [Full Text] [Related]
15. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. Huzoor-Akbar, Mukhopadhyay A, Anderson KS, Navran SS, Romstedt K, Miller DD, Feller DR. Biochem Pharmacol; 1985 Mar 01; 34(5):641-7. PubMed ID: 3156599 [Abstract] [Full Text] [Related]
16. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism. Fraundorfer PF, Fertel RH, Miller DD, Feller DR. J Pharmacol Exp Ther; 1994 Aug 01; 270(2):665-74. PubMed ID: 7915318 [Abstract] [Full Text] [Related]
17. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors. Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR. Pharmacology; 2001 Jan 01; 62(1):45-55. PubMed ID: 11150922 [Abstract] [Full Text] [Related]
19. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells. Hanasaki K, Nakano K, Kasai H, Arita H. Biochem Pharmacol; 1989 Sep 15; 38(18):2967-76. PubMed ID: 2528958 [Abstract] [Full Text] [Related]
20. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig. Mihara S, Hara S, Ueda M, Ide M, Fujimoto M. Eur J Pharmacol; 1989 Feb 07; 160(3):313-21. PubMed ID: 2523812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]